The new compound 7-methylpyrazolo [4,5-e][1,2,4]thiadiazin-3(2H,4H)-one 1,1-dioxide (5) was synthesized and its novel mono N 2 -or N 4 -substituted derivatives 6 and 7 were prepared by regioselective N-alkylation of 5 with different molar ratios of NaH and alkyl halides. Based on the regioselective alkylation conditions found a facile one-pot synthesis of N 2 ,N 4 -disubstituted pyrazolo [4,5-e][1,2,4] thiadiazines 8 was developed. The structures of the newly synthesized compounds were confirmed by IR, 1 H-NMR, 13 C-NMR and MS spectral analysis.
Introduction
Benzo/heterothiadiazine derivatives have become of particular interest to chemists and biologists because of their broad spectrum of biological activities and potential pharmacological applications. For example, 1,2,4-benzothiadiazines, such as chlorothiazide and diazoxide, are widely used as diuretic and antihypertensive drugs, respectively [1, 2] . Heterocycle-fused thiadiazine derivatives, such as pyrido-, pyrazino-, imidazo-and triazolothiadiazines, show unique potential for the treatment of cerebro-and cardiovascular diseases, cognitive disorders, cancers, viral and bacterial infections [3] [4] [5] [6] .
We recently reported the design and synthesis of 2,4-disubstituted thieno [3,4-e] [1,2,4] thiadiazine derivatives (TTDs) [7] , which selectively block HIV-1 replication at the reverse transcriptase step. The lead compounds QM96639, QM96539 and QM96652 ( Figure 1 ) showed highly potent activity and selectivity against HIV-1 replication in cell culture at low concentration ranges (IC 50 0.05-0.10µM) [8, 9] . In continuation of our research, we decided to undertake a study of the pyrazole series, specifically regarding the 7-methylpyrazolo [4,5-e] [1, 2, 4] thiadiazines, because of the known thiophene-pyrazole bioisosterism [10] . In this paper, we report the preparation of the new regioisomer 7-methylpyrazolo [4,5- 
Results and Discussion

7-Methylpyrazolo[4,5-e][1,2,4]thiadiazin-3(2H, 4H
)-one 1,1-dioxide (5) was synthesized in a similar manner to the thiophene and regioisomeric pyrazole series [7] , by a route which started with hydrazinolysis of ethyl 1-methyl-5-sulfamoylpyrazole-4-carboxylate (1), a commercially available product, with hydrazine hydrate in refluxing ethanol, thus forming the hydrazide 2 in excellent yield. Carboxy azide 3, which was obtained by the reaction of compound 2 with sodium nitrite in diluted hydrochloric acid at ca. 10°C, was pure enough for use in the next ring closure step without further purification. Thus, by refluxing compound 3 in anhydrous toluene, a classical Curtius rearrangement took place through the intermediacy of isocyanate 4 to afford compound 5, a new regioisomer of 6-methylpyrazolo [4,5-e] [1, 2, 4] thiadiazin-3(2H, 4H)-one 1,1-dioxide prepared by our previous work [7] . (Scheme 1). Structural assignments for the ring system in 5 were based on its 1 H-and 13 C-NMR, IR
and MS spectral analysis.
The method used for the regioselective preparation of the new N 2 -substituted 7-methylpyrazolo-[4,5-e][1,2,4]thiadiazine derivatives 6 paralleled that described in ref. [8] , including deprotonation of the 5 using one equivalent of sodium hydride in DMF solvent at a temperature below 5°C, and followed by alkylation with one equivalent of alkyl halide at 80°C for 2-8 h, thus giving the mono N 2 -substituted derivatives 6 (Scheme 2). The crude products were separated by flash column chromatography and purified by recrystallization from ethanol in good yields (81-85%, Table 1 Under these conditions compounds 6 were the predominant products, mainly due to the more acidic nature of the hydrogen at the N 2 position and the resulting easier deprotonation than the hydrogen at the N 4 position, which is caused by the strong electric withdraw effect by the sulfonyl group. Meanwhile, the isomeric 3-O-alkylated pyrazolo [4,5- During our ongoing research on the alkylation reaction of the compound 5, we used 2 equivalents of base rather than only one, in order to perform double deprotonation of 5. Quenching of the disodium salt with one equivalent of the electrophile, we observed complete regioselectivity of the reaction, since only the N 4 -alkylated regioisomers 7 were produced, and none of N 2 -substituted compounds 6 was found. We speculate that the stronger nucleophilicity of N 4 anion allowed a preferential N 4 alkylation. We also deduced that the relatively high steric hindrance afforded by the 1-sulfonyl and 3-carbony groups further disfavored the alkylation at N 2 site.
NaH/R 1 CH 2 X(2:1)
7a-d
The N 4 -alkylated product was confirmed by the chemical shift of the CH 2 signal, and by means of NOE experiments and HMBC sequences to establish long-distance proton/carbon correlations. It was shown that the N 4 -CH 2 correlated exclusively with the both quaternary carbon C-3 and C-4a, which is different from the N 2 -CH 2 , that only correlated with quaternary carbon C-3. A series of N 4 -alkylated derivatives 7a-d were prepared in high yield (80-86%) and the results were shown in Table 2 . [7, 9] . Using to the aforementioned regioselective alkylation method, N 2 ,N 4 -disubstituted derivatives 8 were synthesized in a one-pot reaction, by addition of two equivalents of NaH and one equivalent of R 2 CH 2 X first, followed by addition of one equivalent of R 1 CH 2 X when the synthesis of intermediate 7 (monitored by TLC) was shown to be finished. The crude products 8 were obtained and purified by recrystallization to give white solids in ca. 80% yield (Scheme 4). A series of N 2 ,N 4 -dialkylated derivatives 8a-d was prepared by this method and are listed in Table 3 . The structures of all synthesized compounds were confirmed by 1 H-and 13 C-NMR, IR and MS spectroscopic analysis. -alkylated isomers 6' accompanied the reaction, which often went undetected and thus probably unreported previously. We have also developed an efficient, regioselective alkylation at the N 4 site of 5 by use of a 2:1 molar ration of NaH and alkyl halide. The achieved conditions for the regioselective N-alkylation were used to efficiently prepare the N 2 ,N 4 -dialkylated derivatives 8 by a facile one-pot reaction. This method can be used for the synthesis of other mono N 2 -and N 4 -or N 2 , N 4 -disubstituted heterocyclefused 1,2,4-thiadiazine derivatives.
Experimental Section
General
All melting points were determined on a micromelting point apparatus and are uncorrected. To a solution of compound 5 (1 equiv.) in dry DMF (4 mL) was added sodium hydride (60% dispersion in mineral oil, 1 equiv.) in portions, under an inert atmosphere (N 2 ), while the temperature was kept below 10°C. After stirring for 15 min, the alkyl halide (1 equiv.) was added dropwise. The reaction mixture was stirred at room temperature for 20 min and at 30-50°C for 12-20 h (checked by TLC). After the solvent was evaporated under reduced pressure, the products were separated by flash column chromatography (1:3 ethyl acetate/cyclohexane) to give the compounds 6 and 6' respectively, which were purified by recrystallization from ethanol. [4,5-e] [1, 2, 4] thiadiazine (6'a). Compound 5 was alkylated with benzyl bromide at 30°C for 12h to give 6a and 6'a, which after purification gave white solids: 6a: IR (KBr, [4,5- [4,5- 
2-Benzyl-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo[4,5-e][1,2,4]thiadiazine (6a) and 3-Benzyloxy-7-methyl-1,1-dioxo-4H-pyrazolo
2-(p-Chlorobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo[4,5-e][1,2,4]thiadiazine (6b) and 3-(pchlorobenzyloxy)-7-methyl-1,1-dioxo-4H-pyrazolo
2-(m-Chlorobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo[4,5-e][1,2,4]thiadiazine (6d) and 3-(mChlorobenzyloxy)-7-methyl-1,1-dioxo-4H-pyrazolo
General Procedure for the Preparation of 4-Substituted-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo[4,5-e] [1,2,4]thiadiazines (7a-d)
To a solution of compound 5 (1 equiv.) in dry DMF (4 mL) was added sodium hydride (60% dispersion in mineral oil, 2 equiv.) in portions, under an inert atmosphere (N 2 ) while the temperature was kept below 10°C. After 60 min stirring, the alkyl halide (1 equiv.) was added dropwise. The reaction mixture was stirred at room temperature for 20 min and at 40-60°C for 8-12h (checked by TLC), and acidified with dilute hydrochloric acid (pH 4-6). The crude products obtained after the solvent was evaporated under reduced pressure were then separated by flash column chromatography using the indicated solvent system and purified by recrystallization from ethanol. Benzyl-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo[4,5-e][1,2,4 ]thiadiazine (7a). Compound 5 was reacted with benzyl bromide at 30°C for 10 h to give 7a as a white solid after by flash column chromatography separation (CH 2 Chlorobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo [4,5-e] [1, 2, 4] [4,5- [4,5-e] [1, 2, 4] 
4-
).
4-(p-
4-(p-Bromobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo
4-(m-Chlorobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo
General Procedure for the Preparation of 2,4-Disubstituted 7-methyl-1,1,3-trioxo-2H,4H-pyrazolo [4,5-e][1,2,4]thiadiazine Derivatives 8a-d
To a solution of compound 5 (1 equiv.) in dry DMF (4 mL/mmol) was added sodium hydride (60% dispersion in mineral oil, 2 equiv.) in portions, under an inert atmosphere (N 2 ) and keeping the temperature below 10°C. After stirring for 60 min, the appropriate alkyl halide (R 2 CH 2 X, 1 equiv.) was added dropwise. The reaction mixture was stirred at room temperature for 20 min and at 30-60°C for 8-12h (checked by TLC), then the second alkyl halide (R 1 CH 2 X, 1 equiv.) was added dropwise. Stirring of the mixture was continued for 12-20 h at 40-60°C, and then it was acidified (pH 4-6) with dilute hydrochloric acid. After the solvent was evaporated under reduced pressure, the crude products obtained were purified by recrystallization from ethanol to give 8a-d as white solids. -4-(o-bromobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo [4,5-e] [1, 2, 4] [4,5- 
2-Benzyl
2-(p-Chlorobenzyl)-4-(o-bromobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo
. [4,5- 
2-(p-Chlorobenzyl)-4-(o-chlorobenzyl)-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo
